Month of Birth May Influence the Development of Immune System, Suggests a Study

A recent research suggests that babies born in the month of May are more prone to autoimmune disease like multiple sclerosis than those born in November.

A new study suggests that the birth month of a newborn may have a role in the baby’s immune system development and risk of autoimmune diseases like Multiple Sclerosis (MS).

Children born in the month of May are indicated to have low levels of Vitamin D due to lower exposure to sun than those born in November. Vitamin D deficiency is considered to affect the development of immune system thereby increasing the risk of MS in those who are born in the month of May.

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

Scientists at Queen Mary, University of London, and the University of Oxford analyzed the cord blood samples of 50 babies born in May and 50 babies born in November. The results indicated that vitamin D levels in blood samples of babies born in May were 20% lower than in those born in November. May babies also contained an increased amount of harmful autoreactive T-cells, which are responsible for autoimmune disease likely MS.

However, the authors conclude that long term researches are needed to establish the effect of pre-natal vitamin D supplements on immune system and risk of autoimmune diseases.

Source-Medindia

Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.

Vitamin B12 - An Essential Vitamin
If you feel that the persistent or regular incidences of depression have got nothing to do with what you eat, think again. The reason behind low spirits can be due to insufficient levels vitamin B12.

Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA
FDA has approved the new multiple sclerosis drug, Techfidera, by Biogen.